Peng Li (@PengLi_AI) profile picture

PhD Student @OhioState @HasanovLab AI × Oncology

Joined June 2026
Congratulations to @OSUCCC_James, @OhioStateMedOnc, #PIIO physician-scientist, Dr. Elshad Hasanov (@HasanovLab) on receiving a @GatewayforCR award to fund ZUMRA study, a multicenter phase II clinical trial for patients with #KidneyCancer and #BrainMetastasis! ZUMRA study will test zanzalintinib alone or in combination with belzutifan in patients with untreated or progressive #BrainMetastases, a population often excluded from major clinical trials. The study will evaluate whether these treatments shrink brain metastases, while also assessing safety, duration of cancer control, and survival. An important step toward expanding treatment options and bringing hope to patients with challenging-to-treat kidney cancer. #KidneyCancer #ClinicalTrials #CancerResearch
7
21
724
Grateful to my mentor, @HasanovLab, for presenting our work. #insilicoMetMap turns existing experimental and multi-omics data into focused, testable directions for brain metastasis research.
Excited to share our new #insilicoMetMap model, developed by our 🌟💫🌟 PhD student @PengLi_AI 🧠💻 We asked a different question: Can we learn from METMAP experiments and predict brain-metastatic potential for cell lines that have never been tested? Creating #insilicoMetMap and identifying penetrant-like states and candidate biological targets for further experimental testing. This is exactly how we envision #CodeToClinic: using existing experimental and multi-omics data to build computational models that can prioritize bench experiments, generate biological hypotheses, and potentially reduce the time and resources required for discovery. Congratulations, Peng, and the entire @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team! @NeuroOnc @ASCO
1
45
Our trailblazer @ZuhairMajeed presented #BrainMetCompass at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference! 🧠🧭 💻 Try BrainMetCompass: hasanovlab-brainmetcompass.s… 🎯 PREDICT → PERSONALIZE → PREVENT #BrainMetCompass is our #CodetoClinic ML model designed to predict an individual patient’s risk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention. The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
4
1
13
2,044
Our 🌟 PhD student @MostafaIHA is presenting two posters at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference. One highlights our single-cell and spatial characterization of renal cell carcinoma brain metastases, uncovering how tumor cells adapt to the brain microenvironment and interact with its immune and stromal landscape. bioRxiv preprint: pubmed.ncbi.nlm.nih.gov/4214… The second explores an interpretable machine-learning model integrating genomic mutations and copy-number alterations to predict survival across patients with brain metastases. academic.oup.com/noa/article… Proud to see Mostafa bringing together multi-omics, tumor biology, and AI #CodetoClinic as we work toward better understanding and treating brain metastasis. Great work, Mostafa, and congratulations to the entire team @OSUCCC_James @OhioStatePIIO @OSUWexMed and our collaborators @UTMDAnderson @EmoryUniversity @Hacettepe1967 @EJonasch @bilenma @hanalioglu @ACasasent @nicholas_navin #BrainMetastases #KidneyCancer #SingleCell #SpatialBiology #MachineLearning #PrecisionOncology
5
1
23
2,042
Congratulations to 💫 biostatistician @Tubitak scholar @semihaxozgul on a special milestone: concurrent publications in @myESMO @ESMO_Open and @NeuroOnc #NeuroOncAdvances, alongside her poster presentation at the 2026 SNO/@ASCO #CNSMetastasesConference! 🎉 Her work, “Era-Specific Prognostic Factors and an Interpretable Machine-Learning Survival Model for Renal Cell Carcinoma Brain Metastases,” brings together clinical oncology and interpretable AI to better understand outcomes and personalize prognostication for patients with RCC brain metastases. Proud to see this work from our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team, in collaboration with @UTMDAnderson, move from data → #CodetoClinic. 📄 ESMO Open: sciencedirect.com/science/ar… 📄 Neuro-Oncology Advances #cofirst @ZuhairMajeed : academic.oup.com/noa/article… 💻 Interactive models: hasanov-lab.github.io/tools/… Congratulations, Semiha, and the entire team! 👏 #BrainMetastases #KidneyCancer #MachineLearning #PrecisionOncology #SNO2026 #ASCO
5
8
24
1,617
Proud of our team at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference in Boston, presenting 5 studies: 2 oral presentations and 3 posters, spanning AI/ML prediction of brain metastasis, multi-omics neural networks, genomic survival modeling, and single-cell characterization of RCC brain metastases. Exciting to see our trainees leading these efforts and advancing our mission to better predict, understand, and ultimately prevent brain metastasis. #CodetoClinic #BrainMetastases #CNSMetastases #SNO2026 #ASCO #AI #PrecisionOncology @OhioState @OSUCCC_James @OhioStateMedOnc @OhioStatePIIO
3
10
29
2,040
Pilots complete hundreds of hours of flight ✈️ simulation before carrying hundreds of passengers. Why shouldn’t we apply the same philosophy before enrolling hundreds of patients into clinical trials 💊 💉 ? Excited to share our work on an AI-powered framework, led by #CodetoClinic team @ZuhairMajeed @PengLi_AI @docnurlan that emulates a Phase III trial in #RCC through ML model transfer. Great discussions with @realrickpazdur @US_FDA and @AACR #AACRdrugdev26 Program Chair @lillian_siu on the future of in silico clinical trials, real-world evidence, and AI-driven drug development. I believe in silico trials will become a routine step in clinical development, improving trial design before the first patient is enrolled. #InSilicoTrials #AI #ClinicalTrials #KidneyCancer @OSUCCC_James @OhioStatePIIO @Pelotonia @OSUWexMed @OhioStateMedOnc @KidneyCancer
6
26
1,894
The conference was also an invaluable opportunity to engage with our #buckeye family, colleagues and esteemed leaders in the field of oncology. Looking forward to returning to the lab & continuing our code to clinic mission! 🧬💻 @ASCO @OSUCCC_James @OhioStatePIIO @Pelotonia
1
3
138
Congratulations to our star Heme/Onc fellow, @ConquerCancerFd #ASCOMeritAwardee @ShriyaDeshmukh3, presenting at #ASCO26, the spatial transcriptomic profiling of the tumor microenvironment in metastatic RCC treated with sunitinib. If you missed the presentation: hasanov-lab.github.io/galler… We are grateful to our collaborators at @UTMDAnderson, @EJonasch, for leading this IIT and @KidneyCancer, @sitcancer, @OhioStatePIIO for funding correlative studies, @HasanovLab bioinformaticians @MostafaIHA @joseovandor leading analysis. #ASCO26 #SpatialTranscriptomics #TumorMicroenvironment #PrecisionOncology #MachineLearning #CodeToClinic @ASCOTECAG @OhioState @OhioStateMedOnc @OSUCCC_James @ASCO @Pelotonia
1
4
28
769
Excited to share our #ASCO2026 poster presentation by our postdoc alumni @BetulGokYavuz1 @UChicago 🌟 physician👩‍⚕️👩‍🔬scientist Heme/Onc fellow. Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain Metastases 📜biorxiv.org/content/10.64898… 📽️ hasanov-lab.github.io/galler… This study could not have been possible without multi-institutional collaboration and support from @UTMDAnderson @EJonasch @WinshipAtEmory @bilenma @Hacettepe1967 @hanalioglu @HKUniversity #DavidJHShih, funding and resources @KidneyCancer, @OSUCCC_James @OhioState @OSUPIIO, @HasanovLab bioinformatics team #PengLi @joseovandor @AleLaFerlita90 #KidneyCancer #RCC #BrainMetastases #PrecisionOncology #CancerGenomics #MachineLearning @ASCOTECAG @OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive
1
6
1
24
1,862
Excited to share our #ASCO26 presentation from the @OhioStatePIIO @HasanovLab Biomedical Informatics PhD Student #PengLi and collaborators! Machine learning-based transcriptomic signatures predict treatment outcomes across targeted therapy and immunotherapy regimens in renal cell carcinoma 📽️hasanov-lab.github.io/galler… 📜asco.org/abstracts-presentat… Congratulations to #PengLi and the entire @OhioStateMed @OSUCCC_James #Buckeye team: @OSUWexMed @OhioStateMedOnc @OSU_Urology #OSUPathology @eric_facs @FuatBicer #AmirMortazavi @KimrynRathmell @ZuhairMajeed @semihaxozgul #KidneyCancer #RenalCellCarcinoma #AIinMedicine #MachineLearning #PrecisionOncology #CancerResearch #ASCO #Oncology #TranslationalResearch #CodeToClinic @OSUCCC_James @ASCO @ASCOTECAG @KidneyCancer @OncoAlert @oncodaily @OncLive @urotoday
1
4
21
1,303
Excited to share our upcoming presentations at #ASCO2026 from the @HasanovLab @OhioStatePIIO and collaborators. This year, our team will present 12 studies spanning: hasanov-lab.github.io/public… 🤖 AI/ML precision oncology 🧠 RCC brain metastasis biology 🧫 Spatial & single-cell transcriptomics 🌎 Real-world outcomes research with ML models 💻 In silico clinical trial modeling These projects reflect our 💻 #CodetoClinic 👩‍⚕️👨‍⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care. Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. hasanov-lab.github.io/team/ @OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive #KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch
2
7
3
26
3,589